Article
Author: Song, Zengfang ; Huang, Hongling ; Chen, Yixin ; Gao, Huan ; Shi, Yiran ; Zhao, Hao ; Peng, Zhihai ; Sun, Min ; Chen, Qinghua ; Zhou, Dawang ; Li, Wengang ; Ye, Lilin ; Chen, Kaiyun ; Li, Zifeng ; Tang, Jiayu ; Liu, Yue ; Hou, Yongqiang ; Li, Junhong ; Su, Dongxue ; Liu, Pingguo ; Cheng, Yao ; Xiao, Bailong ; Li, Jiaxin ; Chen, Wei ; Lai, Zhangjian ; Yang, Bingying ; Lin, Yao ; Pan, Lei ; Chen, Lanfen ; Zhang, Jinjia ; Nian, Cheng ; Xing, Yunzhi ; Sun, Xiufeng ; Zhou, Zhien ; Huang, Haitao ; Linghu, Yueyue
Alterations in extracellular matrix (ECM) architecture and stiffness represent hallmarks of cancer. Whether the biomechanical property of ECM impacts the functionality of tumor-reactive CD8+ T cells remains largely unknown. Here, we reveal that the transcription factor (TF) Osr2 integrates biomechanical signaling and facilitates the terminal exhaustion of tumor-reactive CD8+ T cells. Osr2 expression is selectively induced in the terminally exhausted tumor-specific CD8+ T cell subset by coupled T cell receptor (TCR) signaling and biomechanical stress mediated by the Piezo1/calcium/CREB axis. Consistently, depletion of Osr2 alleviates the exhaustion of tumor-specific CD8+ T cells or CAR-T cells, whereas forced Osr2 expression aggravates their exhaustion in solid tumor models. Mechanistically, Osr2 recruits HDAC3 to rewire the epigenetic program for suppressing cytotoxic gene expression and promoting CD8+ T cell exhaustion. Thus, our results unravel Osr2 functions as a biomechanical checkpoint to exacerbate CD8+ T cell exhaustion and could be targeted to potentiate cancer immunotherapy.